Gremese, E., Alivernini, S., Ferraccioli, E. S., & Ferraccioli, G. (2020). Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): Tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations. Clinical immunology (Orlando, Fla.), 214, 108395. https://doi.org/10.1016/j.clim.2020.108395
Style de citation ChicagoGremese, Elisa, Stefano Alivernini, Edoardo Sean Ferraccioli, et Gianfranco Ferraccioli. "Checkpoint Inhibitors (CPI) and Autoimmune Chronic Inflammatory Diseases (ACIDs): Tolerance and Loss of Tolerance in the Occurrence of Immuno-rheumatologic Manifestations." Clinical Immunology (Orlando, Fla.) 214 (2020): 108395. https://dx.doi.org/10.1016/j.clim.2020.108395.
Style de citation MLAGremese, Elisa, et al. "Checkpoint Inhibitors (CPI) and Autoimmune Chronic Inflammatory Diseases (ACIDs): Tolerance and Loss of Tolerance in the Occurrence of Immuno-rheumatologic Manifestations." Clinical Immunology (Orlando, Fla.), vol. 214, 2020, p. 108395.